Antiemetic efficacy and pharmacokinetic analyses of the serotonin antagonist ondansetron (GR 38032F) during multiple-day chemotherapy with cisplatin prior to autologous bone marrow transplantation

J Natl Cancer Inst. 1990 Nov 21;82(22):1776-8. doi: 10.1093/jnci/82.22.1776.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antiemetics / pharmacokinetics*
  • Antiemetics / pharmacology
  • Bone Marrow Transplantation
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects*
  • Combined Modality Therapy
  • Drug Administration Schedule
  • Female
  • Humans
  • Imidazoles / pharmacokinetics*
  • Imidazoles / pharmacology
  • Male
  • Middle Aged
  • Neoplasms / drug therapy
  • Neoplasms / surgery
  • Ondansetron
  • Serotonin Antagonists

Substances

  • Antiemetics
  • Imidazoles
  • Serotonin Antagonists
  • Ondansetron
  • Cisplatin